A comparative study of stereopsis in term and preterm children with and without retinopathy of prematurity

Kang EY 1 , Chong YJ 2 , Chen KJ 1 , Chou HD 1 , Liu L 1 , Hwang YS 1 Show all authors , Lai CC 3 , Wu WC 4

Affiliations 

  • 1 Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan
  • 2 Department of Ophthalmology, Penang General Hospital, Pulau Pinang, Malaysia
  • 3 College of Medicine, Chang Gung University, Taoyuan, Taiwan
  • 4 Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan. weichi666@gmail.com
Graefes Arch Clin Exp Ophthalmol, 2024 Aug;262(8):2685-2694.
PMID: 38507045 DOI: 10.1007/s00417-024-06402-3

Abstract

PURPOSE: To evaluate stereopsis in term-born, preterm, and preterm children with and without retinopathy of prematurity (ROP) and its treatment.

METHODS: The cross-sectional study included 322 children between 3 and 11 years of age born term or preterm, with or without ROP, and with or without treatment for ROP. The ROP treatments were laser therapy, intravitreal injection (IVI) of anti-vascular endothelial growth factor, or their combination. Stereoacuity was measured using the Titmus Stereo Test, and the results among various age groups were analyzed.

RESULTS: Stereopsis was found to improve with increasing age at testing (P  0.05). No significant differences in stereopsis were identified between children with ROP treated with laser versus with IVI (P > 0.05). From multivariate analysis, younger age at testing (P = 0.001) and younger gestational age (P 

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications